Remedi and Nichols discuss glucokinase inhibition as an approach to diabetes treatment

On January 20, Maria S. Remedi, PhD and Colin G. Nichols, PhD had their perspective published in the American Diabetes Association’s diabetes journal, titled “Glucokinase Inhibition: A Novel Treatment for Diabetes?”  “Chronic hyperglycemia increases pancreatic β-cell metabolic activity, contributing to glucotoxicity-induced β-cell failure and loss of functional β-cell mass, potentially in multiple forms of diabetes.”  […]